70
Participants
Start Date
September 5, 2022
Primary Completion Date
February 8, 2023
Study Completion Date
February 8, 2023
In-clinic wear first
Participant will remain in clinic and wear devices adhered on abdomen or arm approximately 27hrs prior to injection
Home wear first
Device will be applied to the abdomen or arm to deliver placebo subcutaneously. After device application, participant will go home and return to clinic before delivery.
Eurofins Optimed, Gières
Lead Sponsor
Becton, Dickinson and Company
INDUSTRY